Amit Sachdev, EVP, Chief Patient Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 42 shares at $222.50 ($9K) on 2020-11-16, disclosed to the SEC on 2020-11-18.
Scheduled sale ($9k) by EVP, Chief Patient Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $222.50 | 12 | $3K | 28.4% |
| 2 | $223.76 | 22 | $5K | 52.4% |
| 3 | $224.44 | 8 | $2K | 19.1% |
| Total | $223.53 avg | 42 | $9K | 100% |
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |